lovastatin has been researched along with MELAS Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dimauro, S; Lai, PS; Pang, AY; Tay, SK; Yap, HK | 1 |
| Abadia, R; Agnus, D; Chariot, P; Charpentier, C; Danan, C; Gherardi, RK | 1 |
2 other study(ies) available for lovastatin and MELAS Syndrome
| Article | Year |
|---|---|
Myotoxicity of lipid-lowering agents in a teenager with MELAS mutation.
Topics: Adolescent; Anticholesteremic Agents; Creatine Kinase; DNA, Mitochondrial; Family Health; Female; Humans; Lovastatin; MELAS Syndrome; Muscle Weakness; Muscular Diseases; Mutation | 2008 |
Simvastatin-induced rhabdomyolysis followed by a MELAS syndrome.
Topics: Anticholesteremic Agents; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; MELAS Syndrome; Middle Aged; Rhabdomyolysis; Simvastatin | 1993 |